Tests of vaginal microbicides in the mouse genital herpes model

Contraception

Volumn 56, Issue 5, 1997, Pages 329-335

  Zeitlin, Larry ^a,b   Whaley, Kevin J ^a,b   Hegarty, Tracy A ^a   Moench, Thomas R ^b   Cone, Richard A ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b REPROTECT INC   (United States)

Author keywords

Genital herpes; Mouse; Sexually transmitted disease; Sperm; Vaginal microbicide

Indexed keywords

CARRAGEENAN; CHLORHEXIDINE; CONCANAVALIN A; DEXTRAN SULFATE; FUCOIDIN; GRAMICIDIN; HEPARIN; MONOCLONAL ANTIBODY; NONOXINOL 9; POLYSTYRENESULFONIC ACID; POVIDONE IODINE; SPERMICIDAL AGENT;

ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CONTRACEPTION; GENITAL HERPES; HERPES SIMPLEX VIRUS 2; INFECTION PREVENTION; INTRAVAGINAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; SEXUALLY TRANSMITTED DISEASE; VIRUS TRANSMISSION;

ANIMALS; ANTI-INFECTIVE AGENTS; ANTIBODIES, MONOCLONAL; ANTIVIRAL AGENTS; CARRAGEENAN; CHLORHEXIDINE; CONCANAVALIN A; FEMALE; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; LACTOGLOBULINS; MICE; MICE, INBRED C57BL; NONOXYNOL; POLYSACCHARIDES; POLYSTYRENES; POVIDONE-IODINE; VAGINA;

EID: 0031451532     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-7824(97)00154-6     Document Type: Article

References (55)

1. Cohen J. Women: absent term in the AIDS research equation. Science 1995;269:777-80.
2. Elias CJ, Heise LL. Challenges for the development of female-controlled vaginal microbicides. AIDS 1994;8:1-9.
3. Rosenberg MJ, Holmes KK. Virucides in prevention of HIV infection. Sex Transm Dis 1993;20:41-4.
4. Stein ZA. HIV prevention: the need for methods women can use. Am J Public Health 1990;80:460-2.
5. Stone AB, Hitchcock PJ. Vaginal microbicides for preventing the sexual transmission of AIDS. AIDS 1994;8(suppl 1):S285-S293.
6. Harrison PF, Rosenfield A, eds. Contraceptive Research and Development. Washington, DC: National Academy Press, 1996.
7. Rosenberg MJ, Davidson AJ, Chen J, Judson FN, Douglas JM. Barrier contraceptives and sexually transmitted diseases in women: a comparison of female-dependent methods and condoms. Am J Public Health 1992;82: 669-74.
8. Whaley KJ, Barratt RA, Zeitlin L, Hoen TE, Cone RA. Nonoxynol-9 protects mice against vaginal transmission of genital herpes infections. J Infect Dis 1993;168: 1009-11.
9. Moench TR, Whaley KJ, Mandrell TD, Bishop BD, Witt CJ, Cone RA. The cat/feline immunodeficiency virus model for transmucosal transmission of AIDS: nonoxynol-9 contraceptive jelly blocks transmission by an infected cell inoculum. AIDS 1993;7:797-802.
10. Neurath AR, Jiang S, Strick N, Lin K, Li YY, Debnath AK. Bovine beta-lactoglobulin modified by 3-hydroxyphthalic anhydride blocks the CD4 cell receptor for HIV. Nature Med 1996;2:230-4.
11. Neurath AR, Li YY, Strick N, Jiang S. A herpesvirus inhibitor from bovine whey. Lancet 1996;347:1703-4.
12. Baba M, Snoeck R, Pauwels R, De Clercq E. Sulfated polysaccharides are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus, and human immunodeficiency virus. Antimicrob Agents Chemother 1988;32:1742-5.
13. Gonzalez ME, Alarcon B, Carrasco L. Polysaccharides as antiviral agents: antiviral activity of carrageenan. Antimicrob Agents Chemother 1987;31:1388-93.
14. Nisbet IT, Graham DM, Spicer PE, Tibbs GJ. Chlorhexidine as an effective agent against Chlamydia trachomatis in vitro and in vivo. Antimicrob Agents Chemother 1979;16:855-7.
15. Bernstein D, Schiff G, Echler G, Prince A, Feller M, Briner W. In vitro virucidal effectiveness of a 0.12% chlorhexidine gluconate mouthrinse. J Dent Res 1990; 69:874-6.
16. Louis SM, Pearson RM. A comparison of the effects of nonoxynol-9 and chlorhexidine on sperm motility. Contraception 1985;32:199-205.
17. Hennessey TD. Antibacterial properties of Hibitane. J Clin Periodontol 1977;4:36-48.
18. Hansen JES, Nielsen C, Vestergaard BF. Inhibition of human immunodeficiency virus 1 and herpes simplex virus 1 infectivity with a broad range of lectins. Scand J Infect Dis 1991;23:425-30.
19. Ito M, Barron AL. Inactivation of herpes simplex virus by concanavalin A. J Virol 1974;13:1312-8.
20. Petronio MG, Mansi A, Gallinelli C, Pisani S, Seganti L, Chiarini F. In vitro effect of natural and semi-synthetic carbohydrate polymers on Chlamydia trachomatis infection. Chemotherapy 1997;43:211-7.
21. Oehninger S, Clark GF, Acosta AA, Hodgen GD. Nature of the inhibitory effect of complex saccharide moieties on the tight binding of human spermatozoa to the human zona pellucida. Fertil Steril 1991;55:165-9.
22. Bourinbaiar AS, Lee-Huang S. Comparative in vitro study of contraceptive agents with anti-HIV activity: gramicidin, nonoxynol-9, and gossypol. Contraception 1994;49:131-7.
23. Kuo C-C, Grayston T. Interaction of Chlamydia trachomatis organisms and HeLa 229 cells. Infect Immun 1976;13:1103-9.
24. Matthews R, Hodgetts S, Burnie J. Preliminary assessment of a human recombinant antibody fragment to hsp90 in murine invasive candidiasis. J Infect Dis 1995;171:1668-71.
25. Byrne GI, Stephens RS, Ada G, et al. Workshop on in vitro neutralization of Chlamydia trachomatis: summary of proceedings. J Infect Dis 1993;168:415-20.
26. Williamson RA, Burioni R, Sanna PP, Partridge LJ, Barbas CF, Burton DR. Human monoclonal antibodies against a plethora of viral pathogens from single combinatorial libraries. Proc Natl Acad Sci 1993;90:4141-5.
27. Qiao M, Macnaughton TB, Gowans EJ. Adsorption and penetration of hepatitis B virus in a nonpermissive cell line. Virology 1994;210:356-63.
28. Christensen ND, Cladel NM, Reed CA. Postattachment neutralization of papillomaviruses by monoclonal and polyclonal antibodies. Virology 1995;207: 136-42.
29. Isojima S, Kameda K, Tsuji Y, Shigeta M, Ikeda Y, Koyama K. Establishment and characterization of a human hybridoma secreting monoclonal antibody with high titers of sperm immobilizing and agglutinating activities against human seminal plasma. Am J Reprod Immunol 1987;10:67-78.
30. Jones SA, Marchitto KS, Miller JN, Norgard MV. Monoclonal antibody with hemagglutination, immobilization, and neutralization activities defines an immunodominant, 47,000 mol wt, surface-exposed immunogen of Treponema pallidum. J Exp Med 1984;160:1404-20.
31. Moav N, Draghi E, David A, Gold D. Anti-Trichomonas vaginalis monoclonal antibodies inducing complement-dependent cytotoxicity. Immunology 1988;63: 63-9.
32. Smith DG, Russell WC, Thirkell D. Adherence of Ureaplasma urealyticum to human epithelial cells. Microbiology 1994;140:2893-8.
33. Garg S, Doncel G, Chabra S, Upadhyay SN, Talwar GP. Synergistic spermicidal activity of neem seed extract, reetha saponins and quinine hydrochloride. Contraception 1994;50:185-90.
34. Shubair M, Larsen B. Growth inhibition of Candida albicans and other medically important yeasts by vaginal contraceptive products. Gynecol Obstet Invest 1990;29:67-70.
35. Patton DL, Wang S-K, Kuo C-C. In vitro activity of nonoxynol-9 on HeLa 229 cells and primary monkey cervical epithelial cells infected with Chlamydia trachomatis. Antimicrob Agents Chemother 1992;36: 1478-82.
36. Malkovsky M, Newell A, Dalgleish AG. Inactivation of HIV by nonoxynol-9. Lancet 1988;19:645.
37. Asculai SS, Weis MT, Rancourt MW, Kupferberg AB. Inactivation of herpes simplex viruses by nonionic surfactants. Antimicrob Agents Chemother 1978;13: 686-90.
38. Cowan ME, Cree GE. A note on the susceptibility of N. gonorrhoeae to contraceptive agent Nonyl-P. Br J Vener Dis 1973;49:65-6.
39. Sugarman B, Mummaw N. Effects of antimicrobial agents on growth and chemotaxis of Trichomonas vaginalis. Antimicrob Agents Chemother 1988;32:1323-6.
40. Amortegui AJ, Melder RJ, Meyer MP, Singh B. The effect of chemical intravaginal contraceptives and Betadine on Ureaplasma urealyticum. Contraception 1984;30:135-41.
41. Foldesy RG, Homm RE, Levinson SL, Hahn DW. Multiple actions of a novel vaginal contraceptive compound, ORF 13904. Fertil Steril 1986;45:550-5.
42. Amstey MS, Metcalf S. Effect of povidone-iodine on herpesvirus type 2 in vitro. Obstet Gynecol 1975;46: 528-9.
43. Sokal DC, Hermonat PL. Inactivation of papillomavirus by low concentrations of povidone-iodine. Sex Transm Dis 1995;22:22-4.
44. Zamora JL. Chemical and microbiologic characteristics and toxicity of povidone-iodine solutions. Am J Surg 1986;151:400-6.
45. Eis AM, Schneweis KE. Pathogenesis of genital herpes simplex virus infection in mice. Med Microbiol Immunol 1986;175:281-92.
46. Richards JT, Kern ER, Overall JC, Glasgow LA. Differences in neurovirulence among isolates of herpes simplex virus types 1 and 2 in mice using four routes of infection. J Infect Dis 1981;144:464-71.
47. Walz MA, Price RW, Hayashi K, Katz BJ, Notkins AL. Effect of immunization on acute and latent infections of vaginouterine tissue with herpes simplex virus types 1 and 2. J Infect Dis 1977;135:744-52.
48. Neyts J, De Clercq E. Effect of polyanionic compounds on intracutaneous and intravaginal herpesvirus infection in mice: impact on the search for vaginal microbicides with anti-HIV activity. J Acquired Immune Defic Syndr 1995;10:8-12.
49. Whaley KJ, Zeitlin L, Barratt RA, Hoen TE, Cone RA. Passive immunization of the vagina protects mice against vaginal transmission of genital herpes infections. J Infect Dis 1994;169:647-9.
50. 2 fragments protect mice from vaginal transmission of HSV-2. Virology 1996;225:213-5.
51. Matthews DE, Farewell V. Using and Understanding Medical Statistics. Basel, Karger, 1985:20-38.
52. Vorherr H, Vorherr UF, Mehta P, Ulrich JA, Messer RH. Vaginal absorption of povidone-iodine. JAMA 1980;244: 2628-9.
53. Cone RA, Whaley KJ. Monoclonal antibodies for reproductive health: Part I. Preventing sexual transmission of disease and pregnancy with topically applied antibodies. Am J Reprod Immunol 1994;32:114-31.
54. Roddy RE, Cordero M, Cordero C, Fortney JA. A dosing study of nonoxynol-9 and genital irritation. Int J Sex Transm Dis AIDS 1993;4:165-70.
55. Elias CJ, Coggins C. Female-controlled methods to prevent sexual transmission of HIV. AIDS 1996;10: S43-51.